Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term follow-up of early oxytocin treatment in infants with Prader-Willi syndrome (OTBB2 cohort)
2016-004325-16Phase 4Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Nov 2016
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4 trial of oxytocin in Prader-Willi syndrome (PWS) (2 cohorts), sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: Communication skills (Vineland-II). Started Nov 2016; status: completed.
02
Drugs
oxytocin
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on 2016-004325-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004325-16.